SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 118 filers reported holding SYNAGEVA BIOPHARMA CORP in Q2 2014. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $155,620,000 | +286.0% | 1,595,614 | +267.2% | 0.03% | +87.5% |
| Q4 2014 | $40,321,000 | +1.4% | 434,542 | -24.9% | 0.02% | -5.9% |
| Q3 2014 | $39,773,000 | +2861.5% | 578,260 | +4416.6% | 0.02% | +1600.0% |
| Q2 2014 | $1,343,000 | -85.7% | 12,803 | -88.7% | 0.00% | -75.0% |
| Q1 2014 | $9,423,000 | +699.2% | 113,583 | +523.4% | 0.00% | +300.0% |
| Q4 2013 | $1,179,000 | -57.6% | 18,221 | -58.5% | 0.00% | 0.0% |
| Q3 2013 | $2,783,000 | -68.4% | 43,904 | -79.1% | 0.00% | -80.0% |
| Q2 2013 | $8,804,000 | – | 209,742 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 10,660,432 | $1,117,213,000 | 13.68% |
| BB BIOTECH AG | 898,476 | $94,160,000 | 4.47% |
| SECTORAL ASSET MANAGEMENT INC | 516,445 | $54,123,000 | 2.29% |
| Ghost Tree Capital, LLC | 30,000 | $3,144,000 | 2.22% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,521,000 | $369,001,000 | 1.48% |
| Pier Capital, LLC | 83,493 | $8,750,000 | 1.24% |
| ArrowMark Colorado Holdings LLC | 197,613 | $20,710,000 | 0.59% |
| PALISADE CAPITAL MANAGEMENT, LP | 120,779 | $12,658,000 | 0.31% |
| FORTALEZA ASSET MANAGEMENT INC/ | 5,440 | $570,000 | 0.26% |
| Tradeworx Inc. | 2,936 | $308,000 | 0.25% |